AstraZeneca drug Lynparza shows promise in prostate cancer trial
April 21, 2015 at 09:30 AM EDT
LONDON, April 21 (Reuters) - AstraZeneca's recently approved ovarian cancer drug Lynparza, or olaparib, can also help men with prostate cancer, according to new clinical trial results on Tuesday.
